MARKET analysts at Datamonitor
have forecast that Novartis will
deliver the strongest prescription
drug sales growth of all Big
Pharma’s for the period 2009 - 2015.
The prediction, based on its
annual “organic performance”,
foresees that the company will have
an annual growth rate of 4% which
would result in around $10 billion
in sales.
Conversely, Datamonitor analysts
have forecast an average annual
growth rate for Big Pharma in
general of 1.4%.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 10
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.